{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:59:07Z","timestamp":1778079547857,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671520"],"award-info":[{"award-number":["81671520"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Low serum progesterone on the day of frozen embryo transfer (FET) is associated with diminished pregnancy rates in artificial endometrium preparation cycles, but there is no consensus on whether strengthened luteal phase support (LPS) benefits patients with low progesterone on the FET day in artificial cycles. This single-centre, large-sample retrospective trial was designed to investigate the contribution of strengthened LPS to pregnancy outcomes for groups with low progesterone levels on the FET day in artificial endometrium preparation cycles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Women who had undergone the first artificial endometrium preparation cycle after a freeze-all protocol in our clinic from 2016 to 2018 were classified into two groups depending on their serum progesterone levels on the FET day. Routine LPS was administered to group B (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0\u2265\u200910.0\u2009ng\/ml on the FET day,\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u20091261), and strengthened LPS (routine LPS+ im P 40\u2009mg daily) was administered to group A (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u200910.0\u2009ng\/ml on the FET day,\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u20091295). The primary endpoint was the live birth rate, and the secondary endpoints were clinical pregnancy, miscarriage and neonatal outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The results showed that the clinical pregnancy rate was significantly lower in group A than in group B (48.4% vs 53.2%, adjusted risk ratio (aRR) 0.81, 95% confidence interval (CI) 0.68, 0.96), whereas miscarriage rates were similar between the two groups (16.0% vs 14.7%, aRR 1.09, 95% CI 0.77, 1.54). The live birth rate was slightly lower in group A than in group B (39.5% vs 43.3%, aRR 0.84, 95% CI 0.70, 1.0). Birthweights and other neonatal outcomes were similar between the two groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results indicated that the serum progesterone level on the FET day was one of the risk factors predicting the chances of pregnancy in artificial endometrium preparation cycles, and strengthened LPS in patients with low progesterone on the FET day might help to provide a reasonable pregnancy outcome in artificial cycles, although further prospective evidence is needed to confirm this possibility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12958-021-00747-8","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:02:57Z","timestamp":1619136177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Strengthened luteal phase support for patients with low serum progesterone on the day of frozen embryo transfer in artificial endometrial preparation cycles: a large-sample retrospective trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Hongyuan","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjuan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7635-4401","authenticated-orcid":false,"given":"Qiuju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"issue":"5","key":"747_CR1","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/humrep\/deh762","volume":"20","author":"F Nawroth","year":"2005","unstructured":"Nawroth F, Ludwig M. What is the 'ideal' duration of progesterone supplementation before the transfer of cryopreserved-thawed embryos in estrogen\/progesterone replacement protocols? Hum Reprod. 2005;20(5):1127\u201334. https:\/\/doi.org\/10.1093\/humrep\/deh762.","journal-title":"Hum Reprod"},{"issue":"1","key":"747_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12958-019-0549-9","volume":"17","author":"FK Boynukalin","year":"2019","unstructured":"Boynukalin FK, Gultomruk M, Turgut E, Demir B, Findikli N, Serdarogullari M, et al. Measuring the serum progesterone level on the day of transfer can be an additional tool to maximize ongoing pregnancies in single euploid frozen blastocyst transfers. Reprod Biol Endocrinol. 2019;17(1):102. https:\/\/doi.org\/10.1186\/s12958-019-0549-9.","journal-title":"Reprod Biol Endocrinol"},{"issue":"7","key":"747_CR3","volume":"2015","author":"M van der Linden","year":"2015","unstructured":"van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev. 2015;2015(7):CD009154.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"747_CR4","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1210\/jc.2013-3937","volume":"99","author":"RJ Paulson","year":"2014","unstructured":"Paulson RJ, Collins MG, Yankov VI. Progesterone pharmacokinetics and pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized progesterone vaginal insert. J Clin Endocrinol Metab. 2014;99(11):4241\u20139. https:\/\/doi.org\/10.1210\/jc.2013-3937.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"747_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10815-014-0199-y","volume":"31","author":"PC Brady","year":"2014","unstructured":"Brady PC, Kaser DJ, Ginsburg ES, Ashby RK, Missmer SA, Correia KF, et al. Serum progesterone concentration on day of embryo transfer in donor oocyte cycles. J Assist Reprod Genet. 2014;31(5):569\u201375. https:\/\/doi.org\/10.1007\/s10815-014-0199-y.","journal-title":"J Assist Reprod Genet"},{"issue":"12","key":"747_CR6","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1093\/humrep\/dex316","volume":"32","author":"E Labarta","year":"2017","unstructured":"Labarta E, Mariani G, Holtmann N, Celada P, Remoh\u00ed J, Bosch E. Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study. Hum Reprod. 2017;32(12):2437\u201342. https:\/\/doi.org\/10.1093\/humrep\/dex316.","journal-title":"Hum Reprod"},{"issue":"5","key":"747_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/09513590.2018.1534952","volume":"35","author":"S Gaggiotti-Marre","year":"2019","unstructured":"Gaggiotti-Marre S, Martinez F, Coll L, Garcia S, \u00c1lvarez M, Parriego M, et al. Low serum progesterone the day prior to frozen embryo transfer of euploid embryos is associated with significant reduction in live birth rates. Gynecol Endocrinol. 2019;35(5):439\u201342. https:\/\/doi.org\/10.1080\/09513590.2018.1534952.","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"747_CR8","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s10815-020-01713-w","volume":"37","author":"M Volovsky","year":"2020","unstructured":"Volovsky M, Pakes C, Rozen G, Polyakov A. Do serum progesterone levels on day of embryo transfer influence pregnancy outcomes in artificial frozen-thaw cycles? J Assist Reprod Genet. 2020;37(5):1129\u201335. https:\/\/doi.org\/10.1007\/s10815-020-01713-w.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"747_CR9","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.rbmo.2020.01.031","volume":"40","author":"M Polat","year":"2020","unstructured":"Polat M, Mumusoglu S, Bozdag G, Ozbek IY, Humaidan P, Yarali H. Addition of intramuscular progesterone to vaginal progesterone in hormone replacement therapy in vitrified-warmed blastocyst transfer cycles. Reprod BioMed Online. 2020;40(6):812\u20138. https:\/\/doi.org\/10.1016\/j.rbmo.2020.01.031.","journal-title":"Reprod BioMed Online"},{"issue":"1\u20132","key":"747_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0165-0378(01)00136-X","volume":"55","author":"DK Gardner","year":"2002","unstructured":"Gardner DK, Lane M, Schoolcraft WB. Physiology and culture of the human blastocyst. J Reprod Immunol. 2002;55(1\u20132):85\u2013100. https:\/\/doi.org\/10.1016\/S0165-0378(01)00136-X.","journal-title":"J Reprod Immunol"},{"issue":"3","key":"747_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S1472-6483(10)60837-1","volume":"11","author":"M Kuwayama","year":"2005","unstructured":"Kuwayama M, Vajta G, Kato O, Leibo SP. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod BioMed Online. 2005;11(3):300\u20138. https:\/\/doi.org\/10.1016\/S1472-6483(10)60837-1.","journal-title":"Reprod BioMed Online"},{"issue":"2","key":"747_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1055\/s-0035-1545363","volume":"33","author":"EH Yanushpolsky","year":"2015","unstructured":"Yanushpolsky EH. Luteal phase support in in vitro fertilization. Semin Reprod Med. 2015;33(2):118\u201327. https:\/\/doi.org\/10.1055\/s-0035-1545363.","journal-title":"Semin Reprod Med"},{"issue":"2","key":"747_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/humupd\/6.2.139","volume":"6","author":"A Tavaniotou","year":"2000","unstructured":"Tavaniotou A, Smitz J, Bourgain C, Devroey P. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum Reprod Update. 2000;6(2):139\u201348. https:\/\/doi.org\/10.1093\/humupd\/6.2.139.","journal-title":"Hum Reprod Update"},{"key":"747_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3389\/fendo.2020.00500","volume":"11","author":"F Di Guardo","year":"2020","unstructured":"Di Guardo F, Midassi H, Racca A, Tournaye H, De Vos M, Blockeel C. Luteal phase support in IVF: comparison between evidence-based medicine and real-life practices. Front Endocrinol. 2020;11:500. https:\/\/doi.org\/10.3389\/fendo.2020.00500.","journal-title":"Front Endocrinol"},{"issue":"2","key":"747_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.fertnstert.2017.11.004","volume":"109","author":"K Devine","year":"2018","unstructured":"Devine K, Richter KS, Widra EA, McKeeby JL. Vitrified blastocyst transfer cycles with the use of only vaginal progesterone replacement with Endometrin have inferior ongoing pregnancy rates: results from the planned interim analysis of a three-arm randomized controlled noninferiority trial. Fertil Steril. 2018;109(2):266\u201375. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.11.004.","journal-title":"Fertil Steril"},{"issue":"5","key":"747_CR16","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.rbmo.2018.08.022","volume":"37","author":"B Alsbjerg","year":"2018","unstructured":"Alsbjerg B, Thomsen L, Elbaek HO, Laursen R, Povlsen BB, Haahr T, et al. Progesterone levels on pregnancy test day after hormone replacement therapy-cryopreserved embryo transfer cycles and related reproductive outcomes. Reprod BioMed Online. 2018;37(5):641\u20137. https:\/\/doi.org\/10.1016\/j.rbmo.2018.08.022.","journal-title":"Reprod BioMed Online"},{"issue":"2","key":"747_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.rbmo.2015.05.005","volume":"31","author":"JL Yovich","year":"2015","unstructured":"Yovich JL, Conceicao JL, Stanger JD, Hinchliffe PM, Keane KN. Mid-luteal serum progesterone concentrations govern implantation rates for cryopreserved embryo transfers conducted under hormone replacement. Reprod BioMed Online. 2015;31(2):180\u201391. https:\/\/doi.org\/10.1016\/j.rbmo.2015.05.005.","journal-title":"Reprod BioMed Online"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-021-00747-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-021-00747-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-021-00747-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:03:02Z","timestamp":1619136182000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-021-00747-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["747"],"URL":"https:\/\/doi.org\/10.1186\/s12958-021-00747-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-134070\/v1","asserted-by":"object"}]},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]},"assertion":[{"value":"21 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human Ethics Committee approval for the retrospective trial of frozen embryo transfer cycles came from the Institutional Review Board (IRB) of the Shanghai Ninth People\u2019s Hospital on August 20, 2020 (Number: SH9H-2020-T268\u20131).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients consent the data used for research and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have nothing to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}